Subcellular mechanisms of endothelin action in vascular system

被引:56
作者
Masaki, T
Miwa, S
Sawamura, T
Ninomiya, H
Okamoto, Y
机构
[1] Natl Cardiovasc Ctr, Res Inst, Osaka 5658565, Japan
[2] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan
关键词
endothelin; endothelin receptor; endothelial oxidized low density lipoprotein receptor; cationic amino acid transporter;
D O I
10.1016/S0014-2999(99)00252-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To elucidate the role of endothelin in the regulation of vascular function, the cellular and subcellular mechanisms for the synthesis of endothelin and the function of endothelin-receptors have been studied extensively. In this article, recent results regarding these problems are reviewed. (1) Oxidatively modified low-density-lipoprotein (LDL) reduces nitric oxide (NO) release via inhibition of the high-affinity arginine transporter of endothelial cells. (2) Endothelin-1-induced vasoconstriction is mediated by Ca2+ influx through a non-selective cation channel sensitive to 1-[beta-[3-(4-methoxyphenyl)propoxyl]-4-methoxyphenethyl]-1H-imidazole HCl (SK & F96365). (3) A distinct domain of the endothelin-receptor is required for the coupling of different G(alpha)-proteins. (4) Endothelin ETA receptor-mediated mitogenic activity is mediated by two pathways, one classical protein kinase C(PKC)-dependent, and the other phosphoinositide 3-kinase dependent. Both stimulate mitogen-activated protein kinase (MAPK). Endothelin ETB receptor-mediated mitogenic activity is also mediated by the PKC-dependent pathway. In contrast, endothelin ETB receptor-mediates differentiation and apoptosis via G(alpha)i coupling. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 38 条
[1]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[2]   Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors [J].
Daub, H ;
Weiss, FU ;
Wallasch, C ;
Ullrich, A .
NATURE, 1996, 379 (6565) :557-560
[3]   NOVEL RECEPTOR ANTAGONISTS WELCOME A NEW ERA IN ENDOTHELIN BIOLOGY [J].
DOUGLAS, SA ;
MEEK, TD ;
OHLSTEIN, EH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (09) :313-316
[4]  
DOUGLAS SA, 1995, J CARDIOVASC PHARM, V26, pS163
[5]   NITRIC-OXIDE SYNTHASES IN THE CARDIOVASCULAR-SYSTEM [J].
FORSTERMANN, U ;
POLLOCK, JS ;
NAKANE, M .
TRENDS IN CARDIOVASCULAR MEDICINE, 1993, 3 (03) :104-110
[6]   Biphasic activation of p21(ras) by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase [J].
Foschi, M ;
Chari, S ;
Dunn, MJ ;
Sorokin, A .
EMBO JOURNAL, 1997, 16 (21) :6439-6451
[7]   Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans [J].
Haynes, WG ;
Ferro, CJ ;
OKane, KPJ ;
Somerville, D ;
Lomax, CC ;
Webb, DJ .
CIRCULATION, 1996, 93 (10) :1860-1870
[8]   THE HUMAN ENDOTHELIN FAMILY - 3 STRUCTURALLY AND PHARMACOLOGICALLY DISTINCT ISOPEPTIDES PREDICTED BY 3 SEPARATE GENES [J].
INOUE, A ;
YANAGISAWA, M ;
KIMURA, S ;
KASUYA, Y ;
MIYAUCHI, T ;
GOTO, K ;
MASAKI, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2863-2867
[9]   Selective activation of excitation-contraction coupling pathways by ETA and ETB receptors in guinea-pig tracheal smooth muscle [J].
Inui, T ;
Ninomiya, H ;
Sasaki, Y ;
Makatani, M ;
Urade, Y ;
Masaki, T ;
Yamamura, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (04) :893-902
[10]   Activation of three types of voltage-independent Ca2+ channel in A7r5 cells by endothelin-1 as revealed by a novel Ca2+ channel blocker LOE 908 [J].
Iwamuro, Y ;
Miwa, S ;
Zhang, XF ;
Minowa, T ;
Enoki, T ;
Okamoto, Y ;
Hasegawa, H ;
Furutani, H ;
Okazawa, M ;
Ishikawa, M ;
Hashimoto, N ;
Masaki, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (05) :1107-1114